1 - 5.04.2017 - American Association of Cancer Research (AACR) 2017 Annual Meeting


Join InSphero at AACR Booth #1029

Assess efficacy in 3D tumor spheroids that mirror complex tumor microenvironments

InSphero 3D tumor microtissues spheroid model
Visit InSphero at the AACR 2017 Annual Meeting to learn how our 3D InSight™ Oncology Services can help you more effectively screen in 3D tumor spheroid models that more accurately reflect the physiology of the tumor microenvironment. We'll also be previewing our new GravityTRAP™ 384 Microtissue Platform, a first-of-its-kind 384-well platform for high-throughput and high content imaging designed and optimized specifically for use with spheroids. Visit one of our posters, or join us at Booth 1029 to browse our in-booth poster hall. Let's talk 3D in DC!   






What's New at AACR 2017

3D InSight™ Immuno-oncology Services

Assess immune-mediated tumor cell killing in vitro

3D InSight™ Immuno-oncology Services allow you to assess and optimize immuno-therapeutics for immune-cell mediated tumor cell killing using 3D spheroid models that more accurately reflect complex tumor microenvironments.  Discover the advantages of screening single and combinatorial drug efficacy in more physiologically relevant tumor models composed of tumor, stromal, and immune components.


Sneak Peek:  GravityTRAP™384 Microtissue Platform

Achieve superior HCI in 3D tumor spheroids GravityTRAP 384 Microtissue Platform for DILI Screening

At AACR 2017, we'll be previewing our new GravityTRAP™ 384 Microtissue Platform, a spheroid-optimized high-throughput format for tumor microtissues compatible with today's state-of-the-art liquid handling and high content imaging systems. You'll soon be able to harness the benefits of working in more physiologically relevant 3D tumor spheroid models without the fear of aspirating your microtissues and with a flat glass base plate for superior imaging. Watch the video then stop by our booth to learn more.   


Your 3D InSight™ Conference Planner

Conference Dates
April 1-5, 2017

Walter E. Washington Convention Center, Washington, DC  USA


Download the AACR Meeting App
View the AACR Online Meeting Planner

  Poster Presentations

See how the InSphero 3D Select™ Process is being applied to personalized therapeutic approaches for cancer

Thursday April 5, 8:00 AM - 12:00 PM
5781/17 (Section 38): Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy

SDh rd 01

Presented by Dr. Sumeer Dhar, InSphero AG in collaboration with University of Zurich


Thursday April 5, 8:00 AM - 12:00 PM
5780/16 (Section 38): 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictors for clinical outcome of personalized chemotherapy

Presented by Cheng-guang Wu, University of Zurich

In-booth Poster Hall

AACR2017 booth poster immuno oncology

3D ex vivo cell culture platform presents tumor environment to assess targeted immuno-modulatory agents

AACR2017 booth poster NCATS phenotypic screening

Multi-parametric 3D tumor microtissue-based phenotypic compound classification

AACR2017 booth poster tumor relapse

Assessment of tumor recurrence with an in vitro 3D tumor microtissue model


Company video